Zoekresultaten - 32 results
Molecular test algorithms for breast tumours
13, Issue 2, Number 45 (2019) Abstract: In order to advise the Federal Government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests, the ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
socio-professional support. Methods: We requested data from the Belgian Cancer Registry and the Crossroad Bank for Social Security. We included all socially insured Belgian workers diagnosed between 2004 and 2011 with ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
types and women unselected by HPV status. Expert commentary: All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
particular devices before collection of a cervical sample by a clinician. Sample sets are subsequently analysed in a laboratory accredited for HPV testing. Disease verification for all enrolled patients is ...
Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
(i.e., did not attend screening within 1 year of the initial invitation), 51% of whom stated difficulties in taking time off work. 64% of all respondents knew that HPV vaccination was available; only 34% ...
Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
general rollout. Opt-in procedures involving a request for a self-sampler may reduce response rates. Therefore, an affordable device that can be included with the invitation to all nonattendees may yield ...
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
on all aspects of an organised screening programme. Organised CC screening in Poland was introduced in 2007. The purpose of our study was to analyse: (i) adherence of the programme to EuG; (ii) ...
Are 20 human papillomavirus types causing cervical cancer?
Therefore, these types were considered as 1A carcinogens. They all belong to the family of the α-Papillomaviridae, in particular to the species α5 (HPV51), α6 (HPV56), α7 (HPV18, HPV39, HPV45, HPV59) and α9 ...